According to a study, a new weight loss pill that was taken every day can be compared with injections such as Ozempic.
All of them were obese and patients suffering from type 2 diabetes lost an average of 7.2 kg (16 pounds) on average for nine months as part of the test.
The findings hoped that if they were approved by the regulatory agency, the pill could treat both obesity and diabetes in the future.
Orforglipron can be taken all day without restrictions on food and water intake, ELI Lilly, a drug company.
David A Ricks, chairman of ELI Lilly and chief executive, said:
ELI LILLY said that by 2050, he is convinced of the ability to launch orforglipron worldwide to treat chronic diseases such as type 2 diabetes, which is expected to affect about 760 million adults by 2050.
It is also studied as a potential treatment for obstructive sleep apnea and hypertension in adults with obesity.
Demand for weight management drugs such as Mounjaro, Ozempic and Wegovy has soared in the last two years.
The British pharmacy has introduced a new strict rules to crack down on people lying about weight to approach drugs.
And about 200 pounds a month in the UK and $ 1,000 in the United States, the price is already increasing.
Drugs are GLP-1 drugs, drugs taken per week, helping people with type 2 diabetes help to lose weight and manage blood sugar.
GLP-1 drugs increase the level of the incredin (hormone) that is naturally generated by the stomach when eating.
They help your body to produce more insulin, reduce the amount of glucose generated by the liver, and slow down how quickly the food is digested. This means that you can be filled for a longer longer time and therefore eat less.
It has been proven to be effective in dealing with heart failure and alcoholism. In the UK, Mounjaro and Wegovy are prescribed by weight loss. Ozempic is licensed only as a drug of type 2 diabetes, but sometimes prescribed as a weight loss drug.
